Netzwerk

Peter van Hoogevest, is a pharmacist by training (Utrecht University in The Netherlands), who got his PhD degree in biochemistry 1984 at the Utrecht University in The Netherlands. In 1994 he received the degree of Privat Dozent in pharmacy at the University of Basel, Switzerland. His industrial career started at the Biovet Group of the Animal Health Division of Ciba-Geigy Ltd. (Basel) in 1984. Shortly thereafter he obtained a position at the Novel Dosage Form Department of Pharmaceutical Development of the Pharmaceuticals Division of Ciba-Geigy Ltd. After having several positions at this department at Ciba Ltd. and Novartis Ltd. he founded in 1998 together with colleagues of the Pharmaceutical Development Department and reputed industrial managers and scientists the company ADD Advanced Drug Delivery Technologies (Muttenz, CH) and became CEO of this company and was member of the Board of Directors. In 2000 he joined Phares Drug Delivery AG (Muttenz, CH), a company specialized in the delivery of poorly water soluble drug substances, as Managing Director and COO and member of the Board of Directors. Since 2012 he is Managing Director of the Phospholipid Research Center, Heidelberg and Head of the Scientific Department (including the Development Department) of Lipoid GmbH, Ludwigshafen am Rhein, Germany. Because of this work experience and scientific background, he obtained a very broad experience in the pharmaceutical industry covering, business development and pharmaceutical technology development aspects of small and big Pharma industries and the pharmaceutical/cosmetic/dietetic excipient industry. His drug delivery expertise especially in the (phospho)lipid research and development area is underscored by 59 scientific publications, including 7 book chapters, 30 symposium posters, co-promotion of 47 PhD Theses, 13 patents and 44 patent applications.